This study aimed to determine the effects of insulin injection site and interval timing to the control of postprandial glucose in diabetes mellitus patients type 2

Phase 3

Completed

• Conditions: Patient with diabetes type 2.; Non-insulin-dependent diabetes mellitus; E10-E14

• Registration Number: IRCT2017062134690N1
• Lead Sponsor: Agus Santosa

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patient diabetes melitus type2; Age min 40 years old; used insulin therapy, Exclusion criteria: Patient diabetes melitus type2 with complication diabetic (neuropati diabetic, retinopati diabetic, nefropati diabetic); Hiperosmolalitas ketoasidosi; Used Oral Antihyperglycemic Drugs

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Postprandial glucose. Timepoint: 2 hour postprandial. Method of measurement: Glucometer.

Secondary Outcome Measures

Name	Time	Method
Time Interval Administration. Timepoint: 0-30 minutes. Method of measurement: timer.